NANOG and irritable bowel syndrome: In this study, we have shown that MBS and IBS treatment significantly decreased mRNA expression of Nanog, Oct4 and c-Myc in BCL1 cells and Nanog, Oct4, Sox2 and c-Myc in JVM-13 cells compared to untreated cells (Figure 5b).